eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

SCImago Journal & Country Rank
 
4/2006
vol. 5
 
Share:
Share:
more
 
 
abstract:

Influence of route of 17β-oestradiol administration and type of gestagen used on plasma glucose and insulin concentration in postmenopausal women

Tomasz Milewicz
,
Iwona Rogatko
,
Dorota Skucińska
,
Józef Krzysiek
,
Krystyna Sztefko
,
Ewa Kwiatkowska-Panek
,
Stanisław Radowicki

Prz Menopauz 2006; 4: 250–256
Online publish date: 2006/09/21
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 

Aim: Comparison of the influence of transdermal and oral route of 17β-oestradiol administration and type of gestagen on plasma glucose and insulin concentration in postmenopausal women.
Materials and methods: 62 women were enrolled in the study. Group A – 25 women received transdermal 17β-oestradiol (Oesclim 50 – Fournier-Solvay) combined with 5 mg oral dydrogesterone daily (Duphaston – Solvay). Group B – 10 women received oral 17β-oestradiol combined with 10 mg of dydrogesterone daily administration (Femoston-Solvay). Group C – 17 women received transdermal 17β-oestradiol (Oesclim 50 – Fournier-Solvay) combined with 5 mg daily oral medroxyprogesterone (Gestomikron – Adamed). Group D – 10 women without treatment. Basic plasma FSH, oestradiol, glucose and insulin as well as glucose and insulin at the 60th minute of OGTT were measured initially and at the 6th and 12th month of the study.
Results: The mean plasma glucose level during OGTT was reduced after 12 months of replacement therapy in group A. Mean plasma fasting glucose was reduced also after 12 months of oral replacement therapy in group B. The mean plasma fasting and glucose stimulated insulin concentrations were higher after 12 months of replacement therapy in group C. No changes in plasma glucose and insulin concentrations were observed in control group D.
Conclusion: Administration of hormone replacement therapy may influence the metabolism of glucose and insulin in postmenopausal women according to the type of gestagen applied.
keywords:

17β-oestradiol, dydrogesterone, medroxyprogesterone, glucose, insulin, postmenopausal women

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe